Trade Secrets Claim Added To Patent Suit Over Delsym

Law360, New York (June 14, 2010, 1:30 PM EDT) -- Reckitt Benckiser Inc. has updated a patent infringement suit against Tris Pharma Inc. over a proposed generic version of its Delsym 7 cough suppressant to include trade secrets misappropriation and unfair competition claims against Tris and one of its vice presidents, who previously worked for RBI's licensing partner.

RBI lodged an amended complaint Friday in the U.S. District Court for the District of New Jersey, updating its allegations against Tris, a direct rival.

RBI's original complaint, filed in June 2009, accused Tris of infringing U.S. Patent...
To view the full article, register now.